Company Search:
Advanced Search
Sponsored Links
Neuland Laboratories Limited Company Snapshot
Neuland Laboratories Limited operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Neuland Laboratories Limited with three other companies in this sector in India: Morepen Laboratories Limited (2017 sales of 5.84 billion Indian Rupees [US$91.21 million] of which 100% was Pharmaceuticals), Astrazeneca Pharma India Ltd (5.40 billion Indian Rupees [US$84.28 million] of which 96% was Healthcare), and Suven Life Sciences Limited (5.44 billion Indian Rupees [US$84.90 million] of which 95% was Intermediaries under Contract Research/M).

Sales Analysis. Neuland Laboratories Limited reported sales of 5.73 billion Indian Rupees (US$89.46 million) for the fiscal year ending March of 2017. This represents an increase of 12.3% versus 2016, when the company's sales were 5.10 billion Indian Rupees.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Neuland Laboratories Limited
  Stock Performance Chart for Neuland Laboratories Limited
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): 850.10
(Figures in Indian Rupees)
1 Week 0.5%   13 Weeks -1.0%  
4 Weeks -27.1%   52 Weeks -16.3%  
Neuland Laboratories Limited Key Data:
  Ticker: NEULANDLAB Country: India
  Exchanges: BOM Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 5,727,421,000
(Year Ending Jan 2018).
Employees: 906
  Currency: Indian Rupees Market Cap: 7,552,504,325
  Fiscal Yr Ends: March Shares Outstanding: 8,884,254
  Share Type: Ordinary Closely Held Shares: 5,104,834
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.